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General Experimental Procedures 
All solvents and chemicals were used as received. Column chromatography was carried 
out using either Merck Geduran Si 60 (40-63 µm) silica gel or a Biotage purification system 
using Biotage or Grace silica columns. Analytical thin layer chromatography was carried 
out using Merck TLC Silica Gel 60 F254 aluminium-backed plates. Components were 
visualised using combinations of ultra-violet lights, potassium permanganate or ninhydrin.  
Proton magnetic resonance spectra (1H NMR) were recorded at 400, 500 or 600 MHz on a 
Bruker Avance spectrometer and are reported as follows: chemical shift δ in ppm (number 
of protons, multiplicity, coupling constant J in Hz, assignment). The solvent used was 
deuterated chloroform or deuterated methanol unless stated otherwise. Residual protic 
solvent was used as the internal reference, setting CDCl3 to δ 7.26 and MeOD-d4 to 3.31. 
The following abbreviations are used: s, singlet; d, doublet; t, triplet; q, quartet; m, 
mulitplet; br, broad or a combination of these. Carbon magnetic resonance spectra (13C 
NMR) were recorded at 100, 125 or 150 MHz on a Bruker Avance spectrometer using 
deuterated chloroform or deuterated methanol and using the central reference of CDCl3 to 
δ 77.0 or MeOD-d4 to δ 49.15 as the internal standard. Mass Spectrometry data were 
collected on either TOF or magnetic sector analysers either at the Department of 
Chemistry, University College London or at the EPSRC UK National Mass Spectroscopy 
Facility at Swansea University. The ionization method is reported in the experimental data.  
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(2,2-Diethoxyethyl)(4-methoxybenzyl)sulfane (3b)1,2 
 
To a stirred solution of bromoacetaldehyde diethyl acetal (3.760 mL, 25 mmol) in EtOH 
(110 mL) and NaOH (1 M, 50 mL) at 0 °C was added para-methoxybenzyl mercaptan 
(3.831 mL, 27.5 mmol) dropwise and the reaction stirred for 2 days. A precipitate formed 
which was removed by filtration and the filtrate reduced in vacuo. The residue was 
dissolved in ether (25 mL) and washed with H2O (25 mL) and then brine (20 mL). The 
organic layers were dried (MgSO4) and reduced in vacuo to give 3b as a light yellow oil 
(3.56 g, 13.2 mmol, 52%); Rf 0.28 (3:1 CH2Cl2:EtOAc); 1H NMR (600 MHz, CDCl3) δ 7.25 
(2H, d, J = 8.5, ArH ), 6.83 (2H, d, J = 8.5, ArH), 4.54 (1H, t, J= 5.5, CH), 3.77 (3H, s, 
OCH3 ), 3.74 (2H, s, ArCH2), 3.64 (2H, dq, J = 9.3, 7.1, 2 × OCH2), 3.51 (2H, dq, J = 9.3, 
7.1, 2 × OCH2)2.57 (2H, d, J = 5.5, SCH2CH), 1.21 (6H, t, J = 7.1, 2 × CH2CH3); 13C NMR 
δ (150 MHz, CDCl3)  δ 158.7, 130.5, 130.3, 114.0, 103.5,  62.3, 55.4, 36.2, 34.0, 15.5 ; IR  
υmax 2973 (C-H), 1609 (Ar), 1509 (Ar), 1300 (C-O), 1244 (ArO-C). 
 
2-((4-Methoxybenzyl)thio)acetaldehyde (4)2 
 
Dilute HCl (2 M, 15 mL) was added to 3b (1.9336 g, 7.158 mmol) in acetone (15 mL) and 
the reaction stirred overnight. The solution was extracted (EtOAc, 2 × 10 mL) and the 
organic layer washed with H2O (10 mL) and then brine (10 mL). The organic layer was 
dried (MgSO4), filtered, and reduced in vacuo to give 20 as a colourless oil (1.39 g, 7.08 
mmol, 99%). Rf 0.4 (9:1 petrol:EtOAc); 1H NMR (600 MHz, CDCl3) δ 9.40 (1H, t, J = 3.5, 
CHO), 7.21 (2H, d, J = 8.6, ArH), 6.85 (2H, d, J = 8.6, ArH), 3.79 (3H, s, OCH3), 3.58 (2H, 
s, ArCH2), 3.07 (2H, d, J = 3.5, CH2CHO); 13C NMR (150 MHz, CDCl3) δ 194.1, 159.0, 
130.5, 128.9, 114.2, 55.4, 40.3, 35.1; IR max 3006 (C-H), 2834 (C(O)-H), 1714 (C=O),  
1609, 1509, 1301, 1241, 1173, 1028. 
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(E)-N-(2-((4-methoxybenzyl)thio)ethylidene)-2-methylpropane-2-sulfinamide (5) 
 
Copper(II) Sulfate (1.27 g, 7.94 mmol) and aldehyde 4 (779 mg, 3.97 mmol, 1.1 eq) were 
added to a solution of (±)-tert-butyl sulfonamide (438 mg, 3.61 mmol) in anhydrous CH2Cl2 
(7.2 mL). The reaction was stirred at room temperature for 18 h, before filtering through 
Celite. The solvents were removed in vacuo and the residue obtained was purified by 
column chromatography to give 5 as an orange oil (865 mg, 2.89 mmol, 80%). 1H NMR 
(CDCl3, 600 MHz) δ 7.98 (1H, t, J = 5.6, NCH), 7.23 (2H, d, J = 6.5, ArH), 6.85 (2H, d, J = 
6.5, ArH), 3.79 (3H, s, OCH3), 3.66 (2H, s, ArCH2), 3.35 (1H, dd, J = 14.3, 6.0, 1 × 
SCH2CH), 3.31 (1H, dd, J = 14.3, 5.3, 1 × SCH2CH), 1.22 (9H, s, tBu); 13C NMR (CDCl3, 
150 MHz) δ 164.2, 158.9, 130.3, 129.2, 114.1, 57.0, 55.4, 35.02, 34.3, 22.5; LRMS (CI) 
420 (100%), 300 (37%, [M+H]+), 240 (30%), 195 (32%, [M−SOtBu]+), 121 (88%, PMB+); 
HRMS Found 300.10877, C14H22NO2S2 requires 300.10865; IR max (film/cm-1) 2958 (C-
H), 1609 (C=C), 1510 (C=N), 1458 (C=C), 1083 (S=O). 
 
N-(2-((4-Methoxybenzyl)thio)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl)-2-
methylpropane-2-sulfinamide (6) 
 
Using flame dried glassware under an argon atmosphere, CuCl (38.4 mg, 0.388 mmol), 
(±)-BINAP (111.1 mg, 0.1784 mmol) and B2pin2 (1.331 g, 5.242 mmol) were dissolved in 
anhydrous THF (4 mL). KOtBu (1 M in THF, 1.4 mL, 1.4 mmol) was added whilst stirring at 
room temperature. After 10 min, the reaction was cooled to −20 °C and aldehyde 5 
(1.0338 g, 3.4522 mmol) was added followed by MeOH (300 µL, 7.41 mmol) and the 
reaction stirred overnight. The solvent was removed in vacuo and the resultant oil purified 
by flash column chromatography using EtOAc in CH2Cl2 (20 → 35%) to give 6 as an 
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orange oil (878 mg, 2.06 mmol, 60%). 1H NMR (CDCl3, 600 MHz) δ 7.24 (2H, d, J = 8.6, 
ArH), 6.82 (2H, d, J = 8.6, ArH), 3.78 (3H, s, OCH3), 3.71 (1H, d, J = 5.6, NH), 3.69 (2H, s, 
ArCH2S), 3.22-3.17 (1H, m, CHB), 2.77 (1H, dd, J = 13.4, 6.3, 1 × SCH2CH), 2.72 (1H, dd, 
J = 13.4, 7.9,  1 × SCH2CH), 1.25 (s, 6H, 2 × pinacol-CH3), 1.23 (s, 9H, tBu), 1.20 (s, 6H, 2 
× pinacol-CH3); 13C NMR (CDCl3, 150 MHz) δ 158.7, 130.1, 130.0, 114.0, 84.3, 56.2, 55.3, 
41.3 (br), 35.2, 34.6, 25.0, 24.9, 22.6; LRMS (CI) 428 (41%,  [M+H]+), 371 (18%, 
[M−tBu]+), 322 (38%, [M−SOtBu]+), 121 (100%, PMB+); HRMS Found 428.2095, 
C20H34BNO4S2 requires 428.2095; IR max (film/cm-1) 2977 (C-H), 2930 (C-H), 1609 (C=C), 
1511 (C=C), 1544(C=C), 1369 (B-O). 
 
2-((4-Methoxybenzyl)thio)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethanamine 
hydrochloride (7) 
 
A solution of HCl in dioxane (4 M, 585 µL, 2.34 mmol) was added to 6 (99.7 mg, 0.233 
mmol) dissolved in anhydrous MeOH (3 mL) to give a pale yellow solution. The reaction 
was stirred for 3 h.  The solvent was removed in vacuo to give an orange residue (75.3 
mg). The residue was washed with ether, sonicated, and centrifuged to give 7 as a light 
brown solid (68 mg, 0.190 mmol, 82%); mp 166-168 °C). 1H NMR (MeOD-d4, 400 MHz) δ 
7.29 (2H, d, J = 8.7, ArH), 6.89 (2H, d, J = 8.7, ArH) 3.80 (3H, s, OCH3), 3.79 (2H, s, 
ArCH2), 3.01 (1H, dd, J  = 8.7, 4.7, CHB), 2.85 (1H, dd, J = 14.3,4.8, 1 × CH2CH), 2.73 
(1H, dd, J = 14.3, 8.8, 1 × CH2CH), 1.33 (12H, s, 4 × CH3); 13C NMR (MeOD-d4, 100 MHz) 
δ 159.1, 129.9, 129.5, 113.7, 85.5, 74.4, 54.5, 35.1, 30.4, 23.8, 23.7; LRMS (CI) 323 
(100%, [M+H]+), 198 (18%, [M−Bpin]+); HRMS Found 323.18359, C16H27BNO3S requires 
323.1836; IR max (solid/cm-1) 2975 (C-H), 2958 (C-H), 2831 (C-H), 1607, 1583, 1411. 
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2-((4-Methoxybenzyl)thio)ethanamine hydrochloride (8) 
 
 
 
Following procedure for 7, leaving the reaction mixture overnight gave 8. mp 136.9-138.3 
°C; 1H NMR (600 MHz, MeOD) δ 7.27 (2H, d, J = 8.7, ArH), 6.87 (2H, d, J = 8.7, ArH), 3.77 
(3H, s, OCH3), 3.74 (2H, s, ArCH2), 3.01 (2H, t, J = 6.9, CH2N), 2.68 (2H, t, J = 6.9, 
SCH2CH2); 13C NMR (150 MHz, MeOD) δ 160.5, 131.2, 131.0, 115.1, 55.7,  39.7, 35.9, 
29.1; LRMS (CI) m/z 198 (M+H+), 121 (PMB+). Data in accordance with the literature.3 
 
(9H-Fluoren-9-yl)methyl (2-fluoro-2-oxoethyl)carbamate (FMoc-Gly-F)4 
 
 
Using flame dried glassware and under an argon atmosphere, to a solution of Fmoc-Gly-
OH (2.973 g, 10.0 mmol) in anhydrous CH2Cl2 (50 mL) and anhydrous THF (15 mL) was 
added pyridine (810 µL, 10 mmol) followed by the dropwise addition of cyanuric fluoride 
(1.72 mL, 20 mmol). The reaction was stirred overnight. The precipitate and yellow solution 
were washed with ice water (2 × 50 mL) and then brine (50 mL). The organic layer was 
reduced in vacuo. Addition of CH2Cl2 and hexane precipitated FMoc-Gly-F as a yellow 
solid (2.5903 g, 8.654 mmol, 87%); Rf 0.26 (1:9 MeOH:CHCl3); mp 127.5-128.4 °C (lit. 
134-135 °C14); 1H NMR (600 MHz, CDCl3) δ 7.77 (2H, d, J = 7.6, ArH), 7.59 (2H, d, J = 
7.4, ArH), 7.41 (2H, td, J = 7.4, 1.4, ArH), 7.32 (2H, td,  J = 7.5, 1.0, ArH), 5.24 (1H, br s, 
NH), 4.47 (2H, d, J = 6.9, FmocCH2), 4.24 (1H, t, J = 6.9, FmocCHCH2), 4.18 (2H, m, 
NHCH2); 13C NMR (150 MHz, CDCl3) δ 160.7 (d, JC-F = 363 Hz), 156.1, 143.6, 141.4, 
127.9, 127.2, 125.0, 120.1, 67.6, 47.1, 41.2 (d, JC-F = 87 Hz); IR υmax 3333 (N-H), 3212, 
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2970 (C-H), 1865, 1840 (C=O), 1678 (C=O), 1534, 1262, 734 (C-F). 
N-(2-((4-Methoxybenzyl)thio)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)ethyl)acetamide (9a) 
 
Acetyl chloride (65 µL, 0.42 mmol) was added to a solution of 7 (30 mg, 84 µmol) in 
acetonitrile (1 mL) followed by pyridine (40 µL, 0.50 mmol). The reaction was stirred for 18 
h. Solvent was removed in vacuo and EtOAc (3 mL) added. The reaction mixture was 
filtered and the filtrate washed with H2O (3 mL), phosphoric acid (1% in H2O, 3 mL), 
potassium carbonate (2% in H2O, 3 mL) and then brine (3 mL). All aqueous layers were 
back extracted with EtOAc. Removal of solvent in vacuo gave an orange oil which was 
purified by column chromatography (20% EtOAc in CH2Cl2) to give 9a as an orange oil (6.7 
mg, 22%). 1H NMR (CDCl3, 600 MHz) 7.21 (2H, d, J = 8.6, ArH), 7.00 (1H, br s, NH), 6.83 
(2H, d, J = 8.6, ArH), 3.78 (3H, s, OCH3), 3.66 (1H, d, J = 13.6, 1 × ArCH2), 3.63 (1H, d, J 
=  13.6, 1 × ArCH2), 2.81 (1H, dd, J  =14.3, 2.8, 1 × CH2CH), 2.65 (1H, br d, J = 12.2, 
CHB), 2.45 (1H, dd, J = 14.3, 12.8, 1 × CH2CH), 2.05 (3H, s, C(O)CH3), 1.16 (6H, s, 2 × 
pinacol-CH3), 1.15 (6H, s, 2 × pinacol-CH3); 13C NMR (CDCl3, 150 MHz) δ 176.0, 158.8, 
130.7, 130.1, 114.1, 80.4, 55.4, 44.4, 35.2, 34.2, 25.3, 24.9, 18.1; LRMS (CI) 366 (40%, 
[M+H]+), 266 (51%), 243 (33%), 212 (57%, [M−SPMB]+), 121 (100%,  PMB+); HRMS 
Found 366.19151, C18H28BNO4S requires 366.19103; IR max  (film/cm-1) 3260 (N-H), 
2960(C-H), 2924 (C-H), 2853 (C-H), 1609 (C=O), 1511. 
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2-Chloro-N-(2-((4-methoxybenzyl)thio)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)ethyl)acetamide (9b) 
 
Using flame dried glassware and under an argon atmosphere, a solution of 7 (82.3 mg, 
0.193 mmol) in anhydrous CH2Cl2 (1 mL) was cooled to 0 °C. Chloroacetyl chloride (17 µL, 
0.231 mmol) was added followed by the dropwise addition of NMM (30 µL, 0.270 mmol). 
The solution was allowed to warm to room temperature and stirred for 90 min. The 
reaction was cooled to 0 °C and HCl (0.2 M, 7 mL) added. The reaction mixture was 
diluted with EtOAc and the organic layer was separated, dried (MgSO4), filtered and 
concentrated in vacuo to give a brown oil. On addition of Et2O a brown solid formed which 
was filtered. The filtrate was concentrated in vacuo to give 9b as a brown oil (65.4 mg, 
85%). 1H NMR (CDCl3, 600 MHz) δ 7.66 (1H, br s, NH), 7.21 (2H, d, J = 8.7, ArH), 6.83 
(2H, d, J = 8.7, ArH), 4.15 (2H, s, CH2Cl), 3.78 (3H, s, OCH3), 3.67 (2H, s, ArCH2), 2.97 
(1H, br d, J = 11.1, CHB), 2.76 (1H, dd, J = 14.0, 3.0, 1 × CH2CHB), 2.52 (1H, dd, J = 14.0, 
11.6, 1 × CH2CHB), 1.21 (6H, s, 2 × pinacol-CH3), 1.19 (6H, s, 2 × pincaol-CH3); 13C NMR 
(CDCl3, 150 MHz) δ 171.1, 158.8, 130.1 (2C), 114.1, 82.5, 55.4, 41.6 (br), 41.3, 35.4, 33.0, 
24.9, 24.63; LRMS (CI) 402 (41%, [M+H]+, Cl37), 404 (100%, [M+H]+, Cl35);  HRMS Found 
399.1552, C18H28BClNO4S requires 399.1551; IR max (film/cm-1) 2923 (C-H), 1733 (C=O), 
1661, 1593, 1494, 1434. 
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tert-Butyl (2-((2-((4-methoxybenzyl)thio)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)ethyl)amino)-2-oxoethyl)carbamate (10a)  
 
Using flame dried glassware under an argon atmosphere, Boc-Gly-OH (87.5 mg, 0.50 
mmol) was dissolved in anhydrous CH2Cl2 (1.5 mL) and cooled to −20 °C. NMM (66 µL, 
0.60 mmol) was added followed by IBCF (58 µL, 0.45 mmol) and the reaction stirred for 5 
h at −20 °C. HCl salt 23 (23.4 mg, 65.1 µmol) was added followed by NMM (7 µL, 65 µmol) 
and the reaction allowed to warm to rt and stirred for 18 h. The reaction mixture was 
concentrated in vacuo and the resultant oil purified by column chromatography (2% MeOH 
in EtOAc) using deactivated silica (35% H2O w/w) to give 36 as a pale yellow oil (27.9 mg, 
89%). 1H NMR (CDCl3, 600 MHz) δ 7.51 (1H, br s, CHNH), 7.21 (2H, d, J = 8.7, ArH), 6.82 
(2H, d, J = 8.7, ArH), 5.29 (1H, br s, CH2NH), 3.93 (2H, d, J = 5.7, NHCH2), 3.78 (3H, s, 
OCH3), 3.65 (2H, s, ArCH2), 2.81 (1H, br d, J = 11.5, CHB), 2.75 (1H, dd, J = 14.1, 3.2, 1 × 
SCH2CH), 2.46 (1H, dd, J = 14.1, 11.5, 1 × SCH2CH), 1.44 (9H, s,  Bu), 1.18 (6H, s, 2 × 
pinacol-CH3), 1.16 (6H, s, 2 × pinacol-CH3); 13C NMR (CDCl3, 150 MHz) δ 174.9, 158.7, 
130.3, 130.1, 114.1, 81.6, 55.4, 54.0, 41.4, 35.2, 33.6, 29.8, 28.4, 25.0, 24.9, 14.3; LRMS 
(CI) 481 (100%, [M+H]+); HRMS Found 480.2575, C23H37BN2O6S requires 480.2574; IR 
(film/cm-1) 2970 (C-H), 2926 (C-H), 1697 (br, C=O), 1609 (C=O), 1511, 1456. 
 
  
9 
 
(9H-Fluoren-9-yl)methyl(2-((2-((4-methoxybenzyl)thio)-1-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)ethyl)amino)-2-oxoethyl)carbamate (10b) 
 
Using flame dried glassware and under an argon atmosphere FMoc-Gly-F (15.9 mg, 53.0 
µmol) was added to a solution of HCl salt 7 (15.9 mg, 44.2 µmol) in anhydrous CH2Cl2 (1.5 
mL) followed by DIPEA (15 µL, 88 µmol). The reaction was stirred for 18 h. The solution 
was washed with HCl (2 M, 2 × 3 mL), H2O (2 × 3 mL), sodium bicarbonate (2 × 3 mL) and 
H2O (2 × 3 mL). All aqueous layers were back extracted with CH2Cl2. The combined 
organic layers were dried (MgSO4), filtered and concentrated in vacuo to give an orange 
residue which was purified by column chromatography (1% MeOH in CHCl3) using 
deactivated silica (35% H2O w/w) to give 39 as an orange gum (16.0 mg, 60%). 1H NMR 
(CDCl3, 600 MHz) δ 7.77 (2H, d, J = 7.6, FmocH), 7.58 (2H, d, J = 7.4, FmocH), 7.40 (2H, 
t, J = 7.6, FmocH), 7.31 (2H, t, J = 7.4, FmocH), 7.18 (2H, d, J = 8.6, ArH), 7.03 (1H, br s, 
CHNH), 6.79 (2H, d, J = 8.6, ArH), 5.33 (1H, br s, CH2NH), 4.46 (2H, d, J = 6.7, 
FmocCH2), 4.22 (1H, d, J = 6.7, FmocCH2CH), 3.98 (1H, dd, J = 17.3, 5.8, 1 × CH2NH), 
3.92 (1H, dd, J = 17.3, 5.7, 1 × CH2NH), 3.74 (3H, s, OCH3), 3.63 (2H, s, ArCH2S), 2.89 
(1H, br d, J = 10.0, CHB), 2.80 (1H, dd, J = 13.7, 3.4, 1 × CH2CHB), 2.50 (1H, dd, J = 
13.7, 11.6, 1 × CH2CHB), 1.20 (6H, s, 2 × pinacol-CH3), 1.19 (6H, s, 2 × pinacol-CH3); 13C 
NMR (CDCl3, 150 MHz) δ 173.0, 158.7, 156.5, 143.7, 141.4, 130.4, 130.1, 127.9, 127.3, 
125.1, 120.2, 114.1, 82.2, 67.4, 55.4, 47.2, 42.3, 41.0 (br), 35.5, 33.7, 25.1, 24.9; LRMS 
(CI) 603 (3%, [M+H]+), 503 (3%), 381 (9%), 325 (8%), 281 (7%), 207 (7%), 179 (100%, 
[Fmoc−CO2]+), 147 (8%), 121 (36%, PMB+), 103 (17%); HRMS Found 603.27061, 
C33H39BN2O6S requires 603.27001; IR max (film/cm-1) 3300 (N-H), 2970 (C-H), 2928 (C-
H), 1711 (C=O), 1680 (C=O), 1610, 1536, 1511, 1462, 1450. 
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(2,2-Diethoxyethyl)(4-methoxybenzyl)sulfane (3b) 
11 
 
2-((4-methoxybenzyl)thio)acetaldehyde (4) 
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(E)-N-(2-((4-Methoxybenzyl)thio)ethylidene)-2-methylpropane-2-sulfinamide (5) 
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N-(2-((4-Methoxybenzyl)thio)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl)-2-methylpropane-2-
sulfinamide (6) 
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2-((4-Methoxybenzyl)thio)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethanamine hydrochloride (7) 
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2-((4-Methoxybenzyl)thio)ethanamine hydrochloride (8) 
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N-(2-((4-Methoxybenzyl)thio)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl)acetamide (9a) 
  
17 
 
2-Chloro-N-(2-((4-methoxybenzyl)thio)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl)acetamide (9b)
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tert-Butyl (2-((2-((4-methoxybenzyl)thio)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl)amino)-2-
oxoethyl)carbamate (10a)  
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yl)ethyl)amino)-2-oxoethyl)carbamate (10b) 
 
20 
 
References 
(1) Lantos, I.; Razgaitis, C.; Sutton, B. M. J. Heterocycl. Chem. 1982, 19, 1375. 
(2) Yoneda, K.; Ota, A.; Kawashima, Y. Chem. Pharm. Bull. 1993, 41, 876 
(3) Ghosh, S.; Tochtrop, G. P. Tetrahedron Lett. 2009, 50, 1723. 
(4) Bertho, J.-N; Loffet, A.; Pinel, C.; Reuther, F.; Sennyey, G. Tetrahedron Lett. 1991, 32, 
1303. 
